Biochemical pharmacological profile of migraine prophylactics of pizotifen type
Dlohozková, N.; Metys, J.; Valchár, M.; Soucek, R.
Activitas Nervosa Superior 31(4): 300-301
1989
ISSN/ISBN: 0001-7604 PMID: 2638122 Document Number: 334524
Document emailed within 1 workday
Related Documents
Arthur, G.P.; Hornabrook, R.W. 1971: The treatment of migraine with BC 105 (pizotifen): a double blind trial New Zealand Medical Journal 73(464): 5-9Arthur, G.P.; Hornabrook, R.W. 1971: The treatment of migraine with BC 105 (pizotifen): a double blind trial New Zealand Medical Journal 73(464): 5-9
Israil, A.; Ahmed, S.; Rahman, K.M.; Uddin, M.J.; Dey, S.K.; Battacharjee, M.; Mondal, G.; Ali, M.A.; Alam, M.N.; Miah, A.H.; Uddin, M.S. 2013: Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine Mymensingh Medical Journal: Mmj 22(1): 93-100
Poisson, M.; Huguet, F.; Savattier, A.; Bakri-Logeais, F.; Narcisse, G. 1984: A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study Arzneimittel-Forschung 34(2): 199-204
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Manivet, P.; Soliman, H.R.; Callebert, J.; Laplanche, J.L.; Launay, J.M. 2000: Biochemical mechanisms in the physiopathology of migraine Pathologie-Biologie 48(7): 630-641
Cortelli, P.; de Carolis, P.; Sturani, A.; Ligabue, A.; Lugaresi, A.; Agati, R.; Baldrati, A.; Sacquegna, T. 1986: Cardiovascular and biochemical assessment in migraine patients submitted to tilt test Functional Neurology 1(3): 285-290
Ereshefsky, L.; Lacombe, S. 1993: Pharmacological profile of risperidone Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 38(Suppl 3): S80-S88
Goldstein, F.J. 1971: Marijuana--a pharmacological profile American Journal of Pharmacy and the Sciences Supporting Public Health 143(2): 59-65
Sitruk-Ware, R. 2004: Pharmacological profile of progestins Maturitas 47(4): 277-283
Scherer, R. 1978: Plasma-protein profile in inflammation. Biochemical and immunological studies on the pathomechanism of inflammatory changes in the plasma-protein profile of the rat Fortschritte der Medizin 96(6): 280
Mula-Abed, W-Allah.S. 2005: Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus Saudi Medical Journal 26(7): 1158; Author Reply 1158-9
Patel, J.C. 1981: Migraine--a type of headache Indian Journal of Medical Sciences 35(8): 189-192
Maj, J. 1987: Pharmacological profile and mechanism of action of antidepressant drugs Acta Physiologica Polonica 38(4): 289-301
Johns, T.G.; Piper, D.C.; James, G.W. 1979: The pharmacological profile of a potential hypnotic compound RU 31158 Archives Internationales de Pharmacodynamie et de Therapie 240(1): 53-65
Hahn, D.W.; Allen, G.O.; McGuire, J.L. 1977: The pharmacological profile of norgestimate, a new orally active progestin Contraception 16(5): 541-553
Hache, J.; Duchene-Marullaz, P.; Streichenberger, G. 1974: Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm) Therapie 29(1): 81-93
Korsgaard, S. 1980: Mianserin (Tolvon). An antidepressive agent with a new pharmacological profile Ugeskrift for Laeger 142(32): 2067-2068
Markwardt, F. 1976: Biochemical and pharmacological principles of antithrombotic therapy Folia Haematologica 103(3): 293-312
Costa, E. 1983: Coexistence of neuromodulators: biochemical and pharmacological consequences Federation Proceedings 42(12): 2910-2911